Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03289507 · ClinicalTrials.gov registry record · NA
Longvida Curcumin Human Pharmacokinetics Study
A NA study of Healthy, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT03289507: Completed NA study of Healthy, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
NCT03289507 is a NA study of Healthy that has completed, run by Clinical Nutrition Research Center, Illinois Institute of Technology. The registered enrollment target is 9 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03289507, a NA study of Healthy, has completed, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of the study is to characterize the curcumin metabolites of 2 different capsule formulations of curcumin relative to unformulated Curcuma longa extract of Rhizomes including assessing relative bioavailability and absorption/kinetic profile of curcumonoids and their metabolites in human plasma and urine after acute consumption.
Primary Outcome
Differences in plasma metabolites among 3 treatments
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Treatment1
- DIETARY_SUPPLEMENT Treatment2
- DIETARY_SUPPLEMENT Treatment3
Study Locations (1)
Illinois
- Clinical Nutrition Research Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2017-09-19 |
| Est. Completion | 2018-01-30 |
| Phase | NA |
What the finished NCT03289507 record still lists
NCT03289507 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which Treatment1 is the first listed.
NCT03289507 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03289507 about?
NCT03289507 is a clinical study titled "Longvida Curcumin Human Pharmacokinetics Study". The primary objective of the study is to characterize the curcumin metabolites of 2 different capsule formulations of curcumin relative to unformulated Curcuma longa extract of Rhizomes including assessing relative bioavailability and absorption/kinetic profile of curcumonoids and their metabolites ...
What is the current status of trial NCT03289507?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2017-09-19. Estimated completion is 2018-01-30.
What conditions does trial NCT03289507 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT03289507?
The interventions under investigation include: Treatment1 (DIETARY_SUPPLEMENT), Treatment2 (DIETARY_SUPPLEMENT), Treatment3 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03289507?
This trial is sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03289507 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03289507's enrollment target sits among peer trials
9 1057th of 1090 higher than 31 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI